Location History:
- V Frolunda, SE (1981)
- Frolunda, SE (1981 - 1982)
- Kungsbacka, SE (1985 - 1992)
Company Filing History:
Years Active: 1981-1992
Title: The Innovative Journey of Curt H. Appelgren
Introduction
Curt H. Appelgren, an accomplished inventor based in Kungsbacka, Sweden, has made significant contributions to the pharmaceutical industry. With a remarkable portfolio of 16 patents, Appelgren's work focuses on developing new therapeutically active compounds and innovative pharmaceutical preparations.
Latest Patents
Among his latest patents, Appelgren has developed Metoprolol Succinate, a new therapeutically active compound that can be used in various pharmaceutical preparations. Additionally, he has created a Granular Product (IV), which consists of a solid product coated with a water-soluble material. This coating is achieved through a melt process using substances such as polyethylene glycol, xylitol, sorbitol, lactitol, lecithin, and other water-soluble products. These inventions showcase his commitment to advancing pharmaceutical technologies and improving patient care.
Career Highlights
Curt H. Appelgren has worked with notable companies such as Lejus Medical Aktiebolag and Aktiebolaget Hassle. His tenure in these organizations has allowed him to cultivate his expertise in the development of innovative pharmaceutical solutions. His impressive record of patents demonstrates his ability to translate ideas into tangible technologies that benefit the healthcare sector.
Collaborations
Throughout his career, Appelgren has collaborated with talented professionals, including Eva C. Eskilsson and Conny B. Bogentoft. These partnerships have undoubtedly played a role in facilitating the innovative processes that led to his numerous inventions.
Conclusion
Curt H. Appelgren's contributions to the field of pharmaceuticals through his patents reflect his dedication to innovation and improving therapeutic options for patients. His work continues to inspire future generations of inventors and researchers in the pursuit of groundbreaking solutions.